Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation
Authors:
- Crister CebergCCCrister Ceberg
- Bo-Anders JönssonBJBo-Anders Jönsson
- Yolanda PrezadoYolanda Prezado
- Tobias PommerTPTobias Pommer
- Elisabet EnglundEEElisabet Englund
- Gustav GrafströmGGGustav Grafström
- Anneli EdvardssonAEAnneli Edvardsson
- Anna StenvallASAnna Stenvall
- Karin WingårdhKWKarin Wingårdh
- Bertil PerssonBPBertil Persson
- 30 November 2012
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 57 (24) , 8377-8391
Abstract
75 RG2 glioma-carrying Fischer rats were treated by photon activation therapy (PAT) with monochromatic synchrotron radiation and stable thallium. Three groups were treated with thallium in combination with radiation at different energy; immediately below and above the thallium K-edge, and at 50 keV. Three control groups were given irradiation only, thallium only, or no treatment at all. For animals receiving thallium in combination with radiation to 15 Gy at 50 keV, the median survival time was 30 days, which was 67% longer than for the untreated controls (p = 0.0020) and 36% longer than for the group treated with radiation alone (not significant). Treatment with thallium and radiation at the higher energy levels were not effective at the given absorbed dose and thallium concentration. In the groups treated at 50 keV and above the K-edge, several animals exhibited extensive and sometimes contra-lateral edema, neuronal death and frank tissue necrosis. No such marked changes were seen in the other groups. The results were discussed with reference to Monte Carlo calculated electron energy spectra and dose enhancement factors.Keywords
This publication has 27 references indexed in Scilit:
- Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinomaPhysics in Medicine & Biology, 2010
- Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomasJournal of Neuro-Oncology, 2009
- Enhanced Survival and Cure of F98 Glioma–Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon IrradiationClinical Cancer Research, 2007
- Motexafin-Gadolinium Taken UpIn vitroby at Least 90% of Glioblastoma Cell NucleiClinical Cancer Research, 2006
- Absorbed Dose Distribution in Glioma Tumors in Rat Brain After Therapeutic Intratumoral Injection of 201Tl-ChlorideCancer Biotherapy and Radiopharmaceuticals, 2004
- Cell Survival After Auger Electron Emission from Stable Intracellular Indium Exposed to Monochromatic Synchrotron RadiationActa Oncologica, 1996
- Mechanism of high K+ and Tl+ uptake in cultured human glioma cellsCellular and Molecular Neurobiology, 1995
- Necrosis of malignant gliomas after intratumoral injection of 201TI in vivo in the ratAnti-Cancer Drugs, 1995
- The RG2 rat glioma modelJournal of Neuro-Oncology, 1995
- Radiation Enhancement with Iodinated DeoxyuridineInvestigative Radiology, 1982